Here’s Why PGIM Jennison Health Sciences Fund Reduced its Position in Marinus Pharmaceuticals (MRNS)
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Posts Tagged ‘NASDAQ:MRNS’
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q2 2024 Earnings Call Transcript
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q2 2024 Earnings Call Transcript August 13, 2024Marinus Pharmaceuticals, Inc. misses on earnings expectations.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2023 Earnings Call Transcript
Marinus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.74 EPS, expectations were $-0.64. Marinus Pharmaceuticals, Inc.
5 Hyper-Growth Stocks Billionaires Are Loading Up On
This article presents an overview of the 5 Hyper-Growth Stocks Billionaires Are Loading Up On. For a detailed overview of such stocks, read our article, 11 Hyper-Growth Stocks...
5 Most Promising Long-Term Stocks According to Analysts
In this piece, we will take a look at the five most promising long-term stocks according to analysts.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Marinus Pharmaceuticals' Third Quarter 2023 Financial Results and Business Update Call. [Operator Instructions].
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q2 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Marinus Pharmaceuticals’ Second Quarter 2023 Financial Results and Business Update Call.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Marinus Pharmaceuticals’ First Quarter 2023 Financial Results and Business Update Call.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2022 Earnings Call Transcript
Operator: Greetings everyone and welcome to the Marinus Pharmaceuticals' Fourth Quarter and Full-Year 2022 Financial Results and Business Update Call.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings and welcome to the Marinus Pharmaceuticals' Third Quarter 2022 Financial Results and Business Update Call.
Michael Burry Is Dumping These 5 Stocks
In this article, we discuss the 5 stocks that Michael Burry is dumping.
Michael Burry Stock Portfolio: 10 Newest Additions in 2021
In this article, we discuss the newest stocks in Michael Burry's portfolio.
Michael Burry is Loading Up on These 9 Stocks
In this article, we discuss the 9 stocks Michael Burry is loading up on.
Were Hedge Funds Right About Marinus Pharmaceuticals Inc (MRNS)?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Is MRNS A Good Stock To Buy Now?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Hedge Funds Are Crazy About Marinus Pharmaceuticals Inc (MRNS)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Were Hedge Funds Right About Piling Into Marinus Pharmaceuticals Inc (MRNS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Were Hedge Funds Right Selling Marinus Pharmaceuticals Inc (MRNS)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Is Marinus Pharmaceuticals Inc (MRNS) A Good Stock To Buy?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Hedge Funds Are Crazy About Marinus Pharmaceuticals Inc (MRNS)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their ...
Granite Point Capital’s Returns, AUM, and Holdings
Warren Lammert founded Granite Point Capital, a long/short hedge fund with a focus on small-cap companies, in January 2004.
Market Movers Today: Aemetis Inc (AMTX), Ciena Corporation (CIEN), Baytex Energy Corp (BTE), Marinus Pharmaceuticals Inc (MRNS), and More
Shares of biotech Marinus Pharmaceuticals Inc. MRNS, -9.62% slid more than 14% in premarket trade Tuesday, after the company reported a wider-than-expected loss for 2017.
13G Filing: EcoR1 Capital and Marinus Pharmaceuticals Inc (MRNS)
You can access the original SEC filing by clicking here.
13G Filing: Granite Point Capital and Marinus Pharmaceuticals Inc (MRNS)
You can access the original SEC filing by clicking here.
13G Filing: James E. Flynn and Marinus Pharmaceuticals Inc (MRNS)
You can access the original SEC filing by clicking here.
Here’s Why Investors Are Watching Sangamo Biosciences, GNC Holdings, and Three Other Stocks Today
Markets are mixed on Wednesday as investors get ready to digest a flurry of earnings, and await Federal Reserve’s summary of commentary of the current economic condition, also...
Why These 5 Stocks Are Winning Today
The markets have edged lower today on the final trading day of what has been a very crucial week.
5 Stocks That Have Kicked Off the Week on a Sour Note
Crude futures and all three indexes are lower today as investors remain in a risk-off posture before the FOMC meeting later this week and the Brexit vote on the 23rd of this month...
The Stock Picks of This Obscure Hedge Fund Returned 70.5% In 2015; See What It’s Betting On in 2016
Although Los Angeles-based, biotech-focused hedge fund DAFNA Capital Management has been in operation for the past 17 years, chances are that very few people have heard its name...
Marinus Pharmaceuticals Inc (MRNS): Are Hedge Funds Right About This Stock?
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
